Chicago-based Meitheal Pharmaceuticals, along with its Chinese parent, was busy in 2024, adding both biosimilar drugs and ...
More than two years after the passage of the Inflation Reduction Act (“IRA”) and the Centers for Medicare and Medicaid Services’ (“CMS’”) ...
A new study examining the use of high-cost drugs among patients with colorectal cancer and non-small cell lung cancer found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback